1163 related articles for article (PubMed ID: 25845911)
1. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
2. In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice.
Chu M; Tam LS; Zhu J; Jiao D; Liu H; Cai Z; Dong J; Kai Lam CW; Wong CK
Immunobiology; 2017 Mar; 222(3):483-493. PubMed ID: 27769564
[TBL] [Abstract][Full Text] [Related]
3. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
6. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Epstein-Barr virus-induced gene 3 protein (EBI3) in MRL/lpr mice suppresses their lupus nephritis by activating regulatory T cells.
Shinsuke N; Hiroshi I
Autoimmunity; 2013 Nov; 46(7):446-54. PubMed ID: 23845089
[TBL] [Abstract][Full Text] [Related]
8. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
Parietti V; Monneaux F; Décossas M; Muller S
Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
[TBL] [Abstract][Full Text] [Related]
9. Y-27632, a Rho-associated protein kinase inhibitor, inhibits systemic lupus erythematosus.
Wang Y; Lu Y; Chai J; Sun M; Hu X; He W; Ge M; Xie C
Biomed Pharmacother; 2017 Apr; 88():359-366. PubMed ID: 28122300
[TBL] [Abstract][Full Text] [Related]
10. Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus.
Lavi Arab F; Rastin M; Faraji F; Zamani Taghizadeh Rabe S; Tabasi N; Khazaee M; Haghmorad D; Mahmoudi M
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):12-8. PubMed ID: 25318538
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model.
Sharma J; Collins TD; Roach T; Mishra S; Lam BK; Mohamed ZS; Veal AE; Polk TB; Jones A; Cornaby C; Haider MI; Zeumer-Spataro L; Johnson HM; Morel LM; Larkin J
Sci Rep; 2021 Mar; 11(1):6354. PubMed ID: 33737712
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
13. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus.
Cai Z; Wong CK; Dong J; Jiao D; Chu M; Leung PC; Lau CBS; Lau CP; Tam LS; Lam CWK
Chin Med; 2016; 11():23. PubMed ID: 27134645
[TBL] [Abstract][Full Text] [Related]
15. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu.
Divekar AA; Dubey S; Gangalum PR; Singh RR
J Immunol; 2011 Jan; 186(2):924-30. PubMed ID: 21149603
[TBL] [Abstract][Full Text] [Related]
16. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
[TBL] [Abstract][Full Text] [Related]
17. IL-10 regulates murine lupus.
Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
19. Foxd3 suppresses interleukin-10 expression in B cells.
Zhang Y; Wang Z; Xiao H; Liu X; Zhu G; Yu D; Han G; Chen G; Hou C; Ma N; Shen B; Li Y; Wang T; Wang R
Immunology; 2017 Apr; 150(4):478-488. PubMed ID: 27995618
[TBL] [Abstract][Full Text] [Related]
20. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
